SingStrong-A singing and breathing retraining intervention for respiratory and other common symptoms of long COVID: A pilot study.
breathing retraining
dis-ordered breathing
long COVID
lung disease
singing rehabilitation
Journal
Canadian journal of respiratory therapy : CJRT = Revue canadienne de la therapie respiratoire : RCTR
ISSN: 1205-9838
Titre abrégé: Can J Respir Ther
Pays: Canada
ID NLM: 9617402
Informations de publication
Date de publication:
2022
2022
Historique:
entrez:
1
4
2022
pubmed:
2
4
2022
medline:
2
4
2022
Statut:
epublish
Résumé
Management of Long COVID (LC) is hugely challenging for clinicians. This pilot study evaluated a breathing retraining and singing programme (SingStrong for LC) to address common LC symptoms. The study hypothesized that this intervention would improve symptoms impacting disordered breathing and participant wellbeing. The 10-week, bi-weekly online programme was comprised of a 45-min class of mindfulness, breathing retraining, vocal exercises, and singing. Sessions were recorded for non-attenders and conducted by a trained vocal coach experienced in respiratory cohorts. Persons with a confirmed COVID-19 diagnosis and persisting symptoms were invited to participate. Demographic and COVID-19 data were collected, and the DePaul Symptom Questionnaire Short Form (DSQ- SF) and COVID-19 Yorkshire Rehab Screen questionnaires were administered. Post-intervention focus groups were also conducted. Of 27 ( The SingStrong programme shows promise as a viable treatment option for LC sufferers. Future studies are required to further investigate the efficacy of this intervention.
Sections du résumé
Background
UNASSIGNED
Management of Long COVID (LC) is hugely challenging for clinicians. This pilot study evaluated a breathing retraining and singing programme (SingStrong for LC) to address common LC symptoms. The study hypothesized that this intervention would improve symptoms impacting disordered breathing and participant wellbeing.
Methods
UNASSIGNED
The 10-week, bi-weekly online programme was comprised of a 45-min class of mindfulness, breathing retraining, vocal exercises, and singing. Sessions were recorded for non-attenders and conducted by a trained vocal coach experienced in respiratory cohorts. Persons with a confirmed COVID-19 diagnosis and persisting symptoms were invited to participate. Demographic and COVID-19 data were collected, and the DePaul Symptom Questionnaire Short Form (DSQ- SF) and COVID-19 Yorkshire Rehab Screen questionnaires were administered. Post-intervention focus groups were also conducted.
Results
UNASSIGNED
Of 27 (
Conclusion
UNASSIGNED
The SingStrong programme shows promise as a viable treatment option for LC sufferers. Future studies are required to further investigate the efficacy of this intervention.
Identifiants
pubmed: 35359819
doi: 10.29390/cjrt-2021-074
pii: 074
pmc: PMC8906430
doi:
Types de publication
Journal Article
Langues
eng
Pagination
20-27Déclaration de conflit d'intérêts
All authors declare no conflict of interest.
Références
Occup Med (Lond). 2021 Nov 6;71(8):325-327
pubmed: 33479724
Lancet. 2021 Jan 16;397(10270):220-232
pubmed: 33428867
JAMA. 2020 Aug 11;324(6):603-605
pubmed: 32644129
Nurs Health Sci. 2013 Sep;15(3):398-405
pubmed: 23480423
Physiother Theory Pract. 2021 Mar 31;:1-9
pubmed: 33787452
Open Forum Infect Dis. 2021 Sep 09;8(10):ofab440
pubmed: 34631916
Rehabil Psychol. 2019 Nov;64(4):453-462
pubmed: 31318234
Medicine (Baltimore). 2021 Apr 2;100(13):e25339
pubmed: 33787632
Lancet. 2021 Mar 13;397(10278):952-954
pubmed: 33581803
S Afr Med J. 2020 Nov 23;111(1):10-12
pubmed: 33403997
J Health Psychol. 2021 Apr 29;:13591053211012778
pubmed: 33913360
BMJ. 2020 Jul 14;370:m2815
pubmed: 32665317
Nat Med. 2021 Apr;27(4):626-631
pubmed: 33692530
Clin Rev Allergy Immunol. 2021 Feb 20;:
pubmed: 33609255
Lung. 2021 Apr;199(2):113-119
pubmed: 33569660
NPJ Prim Care Respir Med. 2016 Dec 1;26:16080
pubmed: 27906158
Lancet Respir Med. 2021 Feb;9(2):129
pubmed: 33453162
Ther Adv Infect Dis. 2021 Apr 20;8:20499361211009385
pubmed: 33959278
BMJ. 2020 Jul 21;370:m2912
pubmed: 32694164
Radiol Med. 2021 Jan;126(1):40-46
pubmed: 33006087
BMJ. 2021 Jul 26;374:n1648
pubmed: 34312178
J Adv Nurs. 2010 Dec;66(12):2688-700
pubmed: 20825511
J Voice. 2020 Oct 1;:
pubmed: 33051108
Am J Public Health. 2014 Aug;104(8):e25-31
pubmed: 24922170
Sci Rep. 2021 Aug 9;11(1):16144
pubmed: 34373540
Eur J Pharmacol. 2020 Dec 15;889:173644
pubmed: 33053381